The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression Profiling
Abstract
Purpose: Docetaxel is one of the most effective anticancer drugs available in the treatment of breast cancer. Nearly half of the treated patients, however, do not respond to chemotherapy and suffer from side effects. The ability to reliably predict a patient's response based on tumor gene expression will improve therapeutic decision making and save patients from unnecessary side effects. Patients and Methods: A total of 44 breast tumor tissues were sampled by biopsy before treatment with docetaxel, and the response to therapy was clinically evaluated by the degree of reduction in tumor size. Gene expression profiling of the biopsy samples was performed with 2,453 genes using a high-throughput reverse transcriptase polymerase chain reaction technique. Using genes differentially expressed between responders and nonresponders, a diagnostic system based on the weighted-voting algorithm was constructed. Results: This system predicted the clinical response of 26 previously unanalyzed samples with over 80% accuracy, a level promising for clinical applications. Diagnostic profiles in nonresponders were characterized by elevated expression of genes controlling the cellular redox environment (ie, redox genes, such as thioredoxin, glutathione-S-transferase, and peroxiredoxin). Overexpression of these genes protected cultured mammary tumor cells from docetaxel-induced cell death, suggesting that enhancement of the redox system plays a major role in docetaxel resistance. Conclusion: These results suggest that the clinical response to docetaxel can be predicted by gene expression patterns in biopsy samples. The results also suggest that one of the molecular mechanisms of the resistance is activation of a group of redox genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
Physiological functions of thioredoxin and thioredoxin reductase
Arnér, E. S. J., & Holmgren, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01701.x · Cited by 2,525
Furey, T. S., Cristianini, N., Duffy, N., Bednarski, D. W., Schummer, M., & Haussler, D. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.10.906 · Cited by 2,443
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Bear, H. D., Anderson, S., Brown, A., Smith, R., Mamounas, E. P., Fisher, B., Margolese, R., Theoret, H., Soran, A., Wickerham, D. L., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.005 · Cited by 1,118
REDOX REGULATION OF CELLULAR ACTIVATION
Nakamura, H., Nakamura, K., & Yodoi, J. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.351 · Cited by 1,106
Chang, J. C., Wooten, E. C., Tsimelzon, A., Hilsenbeck, S. G., Gutierrez, M. C., Elledge, R., Mohsin, S., Osborne, C. K., Chamness, G. C., Allred, D. C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14023-8 · Cited by 875
Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
Ringel, I., & Horwitz, S. B. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.4.288 · Cited by 677
Cell signalling and the glutathione redox system
Filomeni, G., Rotilio, G., & Ciriolo, M. R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01176-0 · Cited by 357
Dan, S., Tsunoda, T., Kitahara, O., et al. (2002) · PubMed · Cited by 246
Yokomizo, A., Ono, M., Nanri, H., Makino, Y., Ohga, T., Wada, M., Okamoto, T., Yodoi, J., Kuwano, M., & Kohno, K. (1995) · PubMed · Cited by 237
Sasada, T., Iwata, S., Sato, N., Kitaoka, Y., Hirota, K., Nakamura, K., Nishiyama, A., Taniguchi, Y., Takabayashi, A., & Yodoi, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118668 · Cited by 201
The role of β-tubulin isotypes in resistance to antimitotic drugs
Burkhart, C. A., Kavallaris, M., & Horwitz, S. B. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00022-6 · Cited by 198
Ban, N., Takahashi, Y., Takayama, T., Kura, T., Katahira, T., Sakamaki, S., & Niitsu, Y. (1996) · PubMed · Cited by 183
Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial
Heys, S. D., Hutcheon, A. W., Sarkar, T. K., Ogston, K. N., Miller, I. D., Payne, S., Smith, I., Walker, L. G., & Eremin, O. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.s.015 · Cited by 180
Using Gene Expression Ratios to Predict Outcome Among Patients With Mesothelioma
Gordon, G. J., Jensen, R. V., Hsiao, L.-L., Gullans, S. R., Blumenstock, J. E., Richards, W. G., Jaklitsch, M. T., Sugarbaker, D. J., & Bueno, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.8.598 · Cited by 177
Transcript Abundance in Yeast Varies over Six Orders of Magnitude
Holland, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200101200 · Cited by 159
Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma
Kahlos, K., Soini, Y., S�ily, M., Koistinen, P., Kakko, S., P��kk�, P., Holmgren, A., & Kinnula, V. L. (2001) · International Journal of Cancer · Cited by 127
Adaptor-tagged competitive PCR: a novel method for measuring relative gene expression
Kato, Y. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.22.4694 · Cited by 68
Muro, S., Takemasa, I., Oba, S., Matoba, R., Ueno, N., Maruyama, C., Yamashita, R., Sekimoto, M., Yamamoto, H., Nakamori, S., et al. (2003) · Genome biology · doi:10.1186/gb-2003-4-3-r21 · Cited by 67
Self-citationMolecular classification of primary breast tumors possessing distinct prognostic properties
Iwao, K. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.2.199 · Cited by 62
Mutational analysis of the class I β‐tubulin gene in human breast cancer
Hasegawa, S., Miyoshi, Y., Egawa, C., Ishitobi, M., Tamaki, Y., Monden, M., & Noguchi, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10575 · Cited by 56
Self-citationEmerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer
Goble, S. A., & Bear, H. D. (2003) · Surgical Clinics of North America · doi:10.1016/s0039-6109(03)00071-9 · Cited by 50
Oblong, J. E., Chantler, E. L., Gallegos, A. C., Kirkpatrick, D. L., Chen, T., Marshall, N., & Powis, G. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685570 · Cited by 29
Cited by
Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?
Brenton, J. D., Carey, L. A., Ahmed, A. A., & Caldas, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3845 · Cited by 953
Bellmunt, J., Théodore, C., Demkov, T., Komyakov, B., Sengelov, L., Daugaard, G., Caty, A., Carles, J., Jagiello-Gruszfeld, A., Karyakin, O., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5534 · Cited by 766
Gene expression profiling in breast cancer: classification, prognostication, and prediction
Reis-Filho, J. S., & Pusztai, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61539-0 · Cited by 729
Von Hoff, D. D., Stephenson, J. J., Rosen, P., Loesch, D. M., Borad, M. J., Anthony, S., Jameson, G., Brown, S., Cantafio, N., Richards, D. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.5983 · Cited by 647
Sotiriou, C., & Piccart, M. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2173 · Cited by 461
Metadata
- Authors
- Iwao-Koizumi, K., Matoba, R., Ueno, N., Kim, S. J., Ando, A., Miyoshi, Y., Maeda, E., Noguchi, S., & Kato, K.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-01-20
- Volume
- 23
- Issue
- 3
- Pages
- 422-431
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2140486627
- Cited by
- 309
- References
- 28
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.